Resolving Macrophages Counter Osteolysis by Anabolic Actions on Bone Cells

Area of Science:

• Immunology
• Bone Biology
• Regenerative Medicine

Background:

• Inflammatory osteolytic diseases like rheumatoid arthritis and periodontitis involve macrophage activation and increased osteoclast activity, leading to bone loss.
• Macrophage phenotypic plasticity is crucial for tissue healing and resolution of inflammation.

Purpose of the Study:

• To investigate the role of macrophage phenotypic changes in inflammatory osteolysis and healing using a murine periodontitis model.
• To assess the therapeutic potential of inducing proresolving macrophage activation for treating bone loss in inflammatory conditions.

Main Methods:

• Utilized a murine model of periodontitis to track macrophage phenotypes and bone levels.
• Administered clodronate liposomes for macrophage depletion and rosiglitazone (a PPAR-γ agonist) to induce resolving macrophages.
• Conducted in vitro studies on primary bone marrow-derived macrophages activated with IFN-γ/LPS (proinflammatory) or IL-4 (proresolving).

Main Results:

• Proinflammatory macrophage activation correlated with bone loss, while proresolving markers (IL-10, TGF-β, CD206) correlated with bone levels.
• Macrophage depletion prevented bone resorption but impaired regeneration; inducing resolving macrophages reduced bone resorption and enhanced bone formation.
• IL-4-activated resolving macrophages exhibited enhanced resolving functions and direct anabolic actions on bone cells, partly mediated by secreted Cystatin C.

Conclusions:

• Therapeutic induction of proresolving macrophage functions can restore the balance between bone resorption and formation in inflammatory osteolytic diseases.
• Targeting macrophage polarization presents a promising strategy for treating bone loss associated with conditions like periodontitis and rheumatoid arthritis.